PROS1 and COVID-19: Institut Pasteur and the University of Pittsburgh (Pittsburgh, PA, USA) developed a viral vector vaccine against COVID-19, V-591 (TMV-083) using Measles virus Schwarz vaccine strain as vector expressing S protein of SARS-CoV-2 [253].